These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3802141)

  • 1. [Hemodialysis without heparin. The effect on hemocoagulation parameters].
    Charvát J; Kaslíková J; Bláha J; Spánková H; Mlejnková M; Harosová H; Adamová Z
    Cas Lek Cesk; 1986 Dec; 125(49):1508-10. PubMed ID: 3802141
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodialysis without heparin].
    Kasliková J; Bláha J; Charvát J
    Cas Lek Cesk; 1986 Dec; 125(49):1505-7. PubMed ID: 3802140
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of low molecular weight heparin and standard heparin in hemodialysis.
    Bambauer R; Rücker S; Weber U; Köhler M
    ASAIO Trans; 1990; 36(3):M646-9. PubMed ID: 2174689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of various parameters on heparin utilization in short-term hemodialysis].
    Pristautz H; Katschnig H; Schenk H; Steinberger R; Pogglitsch H; Sailer S
    Med Welt; 1979 Dec; 30(49):1846-8. PubMed ID: 44539
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemostasis parameters behaviour during haemodialysis without anticoagulants.
    Casati S; Moia M; Graziani G; Cantaluppi A; Mannucci PM; Ponticelli C
    Life Support Syst; 1983; 1 Suppl 1():144-7. PubMed ID: 6336396
    [No Abstract]   [Full Text] [Related]  

  • 7. Objective assessment of heparin requirements for hemodialysis in humans.
    Ireland H; Lane DA; Curtis JR
    J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Method of evaluating the adequacy of heparinization during hemodialysis].
    Sukhanov VA; Zlokazov VB
    Urol Nefrol (Mosk); 1982; (3):42-4. PubMed ID: 7112773
    [No Abstract]   [Full Text] [Related]  

  • 9. A low molecular heparin fraction as an anticoagulant during hemodialysis.
    Ljungberg B
    Clin Nephrol; 1985 Jul; 24(1):15-20. PubMed ID: 4017295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Control of heparinization in the hemodialysis for acute kidney failure].
    Vogel GE; Goldmann FL; Jelen S; Tempel G
    Med Welt; 1977 May; 28(19):899-902. PubMed ID: 881979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparin in pregnant women undergoing hemodialysis. Doses according to heparin kinetic models].
    Downey P; López ME
    Rev Med Chil; 1993 Jun; 121(6):703-4. PubMed ID: 8278710
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of regional heparinization in hemodialysis operations ("artificial kidney")].
    Agranenko VA; Kaveshnikova BF
    Khirurgiia (Mosk); 1965 Sep; 41(9):84-90. PubMed ID: 5879002
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic monitoring of heparin therapy for regular hemodialysis.
    Khazine F; Simons O
    Artif Organs; 1985 Feb; 9(1):59-61. PubMed ID: 3994553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1983 Feb; 19(2):82-6. PubMed ID: 6839556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of low-molecular weight heparin during hemodialysis].
    Kalinowski M; Pawlak K; Myśliwiec M; Popławski A
    Pol Merkur Lekarski; 1997 Jan; 2(9):208-10. PubMed ID: 10907031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin kinetics during hemodialysis: variation in sensitivity, distribution volume, and dosage.
    Seifert R; Borchert W; Letendre P; Knutson R; Cipolle R
    Ther Drug Monit; 1986; 8(1):32-6. PubMed ID: 3961894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application of heparin--free hemodialysis by hemophan dialyzer].
    Wang S; Li J; Du J
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):284-6, 320. PubMed ID: 7656162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
    Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin kinetics and methods of heparinization during haemodialysis (author's transl)].
    Lopot F
    Cas Lek Cesk; 1980 Feb; 119(5):139-44. PubMed ID: 7379103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.